Renub Research report titled “United States Anesthesia Drugs Market & Forecast” provides a comprehensive analysis of the current state of this market and likely future evolution over the next 5 years. This 74 page report with 56 Figures and 1 Table provides a complete analysis of local and general anesthesia drugs market in United States. This report has been studied from 2 viewpoints.

• General Anesthesia Drugs Market
• Local Anesthesia Drugs Market

General Intravenous Anesthetic Drugs Market has been further divided into

• Propofol
• Benzodiazepines Class (Diazepam and Midazolam)
• Fospropofol Disodium
• Ketamine
• Methohexital Sodium
• Pentobarbital
• Etomidate
• Fentanyl

United States Local Anesthetic Market has been further divided into

• Articane
• Bupivacaine
• Lidocaine
• Mepivacaine
• Prilocaine

Key Players Profile in United States Anesthetic Drugs Market

• Baxter International Inc
• Endo Health Solutions Inc
• Abbott Laboratories
• AstraZeneca

Table of Contents

1. Executive Summary

2. United States Anesthesia Drugs Market (2010 – 2018)

3. United States Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.1 United States Anesthesia Drugs Market Share & Forecast by Type (2010 – 2018)
3.2 United States General Intravenous Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.3 United States Local Anesthesia Drugs Market Share & Forecast (2010 – 2018)
3.4 United States Anesthesia Drugs Market Share & Forecast by Company (2010 – 2018)

4. By Type – United States Anesthesia Drugs Market (2008 – 2018)
4.1 United States General Inhalation Anesthesia Drugs Market (2008 – 2018)
4.2 United States General Intravenous Anesthesia Drugs Market (2008 – 2018)
4.3 United States Local Anesthesia Drugs Market (2008 – 2018)

5. By Drugs – United States General Intravenous Anesthesia Drugs Market (2010 – 2018)
5.1 United States Propofol Market (2010 – 2018)
5.2 United States Benzodiazepines Class (Diazepam and Midazolam) Market (2010 – 2018)
5.3 United States Fospropofol Disodium Market (2010 – 2018)
5.4 United States Ketamine Market (2010 – 2018)
5.5 United States Methohexital Sodium Market (2010 – 2018)
5.6 United States Pentobarbital Market (2010 – 2018)
5.7 United States Etomidate Market (2010 – 2018)
5.8 United States Fentanyl Market (2010 – 2018)

6. By Drugs – United States Local Anesthesia Drugs Market (2008 – 2018)
6.1 United States Articaine Market (2008 – 2018)
6.2 United States Bupivacaine Market (2008 – 2018)
6.3 United States Lidocaine Market (2008 – 2018)
6.4 United States Mepivacaine Market (2008 – 2018)
6.5 United States Prilocaine Market (2008 – 2018)

7. Key Players Profile in United States Anesthesia Drugs Market
7.1 Baxter International Inc. Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.2 Endo Health Solutions Inc. Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.3 Abbott Laboratories Anesthesia Drugs Sales & Forecast (2008 – 2018)
7.4 AstraZeneca Anesthetic Drugs Sales (2009 – 2011)

8. United States Anesthesia Drugs Market – Growth Driver
8.1 Increasing Demand for Anesthesia Service
8.2 Increasing Ageing Population and Prevalence of Cardiovascular Disease in United States
8.2.1 Increasing Ageing Population

9. United States Anesthesia Drugs Market – Challenges
9.1 Shortage of Anesthesia Providers in United States
9.2 Shortage of Anesthesia Drugs in United States

List of Tables

Table 8–1: United States – Cardiovascular Disease Prevalence (Percent), 2010,2015,2020,2025, 2030

List of Figures

Figure 2 1: United States – Anesthesia Drugs Market (Million US$), 2010 – 2013
Figure 2 2: United States – Forecast for Anesthesia Drugs Market (Million US$), 2014 – 2018
Figure 3 1: United States – Anesthesia Drugs Market Share by Type (Percent), 2010 – 2013
Figure 3 2: United States – Forecast for Anesthesia Drugs Market Share by Type (Percent), 2014 – 2018
Figure 3 3: United States – General Intravenous Anesthesia Drugs Market Share (Percent), 2010 – 2013
Figure 3 4: United States – Forecast for General Intravenous Anesthesia Drugs Market Share (Percent), 2014 – 2018
Figure 3 5: United States – Local Anesthesia Drugs Market Share (Percent), 2010 – 2013
Figure 3 6: United States – Forecast for Local Anesthesia Drugs Market Share (Percent), 2014 – 2018
Figure 3 7: United States – Anesthesia Drugs Market Share by Company (Percent), 2010 – 2013
Figure 3 8: United States – Forecast for Anesthesia Drugs Market Share by Company (Percent), 2014 – 2018
Figure 4 1: United States – General Inhalation Anesthesia Drugs Market (Million US$), 2008 – 2013
Figure 4 2: United States – Forecast for General Inhalation Anesthesia Drugs Market (Million US$), 2014 – 2018
Figure 4 3: United States – General Intravenous Anesthesia Drugs Market (Million US$), 2008 – 2013
Figure 4 4: United States – Forecast for General Intravenous Anesthesia Drugs Market (Million US$), 2014 – 2018
Figure 4 5: United States – Local Anesthesia Drugs Market (Million US$), 2008 – 2013
Figure 4 6: United States – Forecast for Local Anesthesia Drugs Market (Million US$), 2014 – 2018
Figure 5 1: United States – Propofol Market (Million US$), 2010 – 2013
Figure 5 2: United States – Forecast for Propofol Market (Million US$), 2014 – 2018
Figure 5 3: United States – Benzodiazepines Class Market (Million US$), 2010 – 2013
Figure 5 4: United States – Forecast for Benzodiazepines Class Market (Million US$), 2014 – 2018
Figure 5 5: United States – Fospropofol Disodium Market (Million US$), 2010 – 2013
Figure 5 6: United States – Forecast for Fospropofol Disodium Market (Million US$), 2014 – 2018
Figure 5 7: United States – Ketamine Market (Million US$), 2010 – 2013
Figure 5 8: United States – Forecast for Ketamine Market (Million US$), 2014 – 2018
Figure 5 9: United States – Methohexital Sodium Market (Million US$), 2010 – 2013
Figure 5 10: United States – Forecast for Methohexital Sodium Market (Million US$), 2014 – 2018
Figure 5 11: United States – Pentobarbital Market (Million US$), 2010 – 2013
Figure 5 12: United States – Forecast for Pentobarbital Market (Million US$), 2014 – 2018
Figure 5 13: United States – Etomidate Market (Million US$), 2010 – 2013
Figure 5 14: United States – Forecast for Etomidate Market (Million US$), 2014 – 2018
Figure 5 15: United States – Fentanyl Market (Million US$), 2010 – 2013
Figure 5 16: United States – Forecast for Fentanyl Market (Million US$), 2014 – 2018
Figure 6 1: United States – Articaine Market (Million US$), 2008 – 2013
Figure 6 2: United States – Forecast for Articane Market (Million US$), 2014 – 2018
Figure 6 3: United States – Bupivacaine Market (Million US$), 2008 – 2013
Figure 6 4: United States – Forecast for Bupivacaine Market (Million US$), 2014 – 2018
Figure 6 5: United States – Lidocaine Market (Million US$), 2008 – 2013
Figure 6 6: United States – Forecast for Lidocaine Market (Million US$), 2014 – 2018
Figure 6 7: United States – Mepivacaine Market (Million US$), 2008 – 2013
Figure 6 8: United States – Forecast for Mepivacaine Market (Million US$), 2014 – 2018
Figure 6 9: United States – Prilocaine Market (Million US$), 2008 – 2013
Figure 6 10: United States – Forecast for Prilocaine Market (Million US$), 2014 – 2018
Figure 7 1: United States – Baxter International Anesthesia Drugs Sales (Million US$), 2008 – 2013
Figure 7 2: United States – Forecast for Baxter International Anesthesia Drugs Sales (Million US$), 2014 – 2018
Figure 7 3: United States – Endo Health Solutions Anesthesia Drugs Sales (Million US$), 2008 – 2013
Figure 7 4: United States – Forecast for Endo Health Solutions Anesthesia Drugs Sales (Million US$), 2014 – 2018
Figure 7 5: United States – Abbott Laboratories Anesthesia Drugs Sales (Million US$), 2008 – 2013
Figure 7 6: United States – Forecast for Abbott Laboratories Anesthesia Drugs Sales (Million US$), 2014 – 2018
Figure 7 7: United States – AstraZeneca Anesthesia Drugs Sales (Million US$), 2009 – 2011
Figure 8 1: United States – Cosmetic Procedures (Number), 1997, 2012, 2013
Figure 8 2: United States – Number of Surgical Procedure (Thousand), 2007 – 2010
Figure 8 3: United States – Ageing Population by Age Group (Thousand), 2009 – 2012
Figure 9 1: United States – By Region Availability of Anesthesia Specialists (Percent), 2010
Figure 9 2: United States – By States Availability of Anesthesia Specialists (Percent), 2010
Figure 9 3: United States – Drugs Shortage (Number), 2006, 2011, 2012
Figure 9 4: United States – Anesthesia Drugs Shortage with the Highest Frequency (Percent), 2012